Home/ Supplements/ Melatonin/ Melatonin SR 2 mg

Melatonin SR 2 mg

product on market Capsule Bio-Tech Pharmacal Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

MicroActive Melatonin is a sustained-release form of the hormone used to regulate sleep-wake cycles. There is strong evidence supporting its efficacy in reducing sleep onset latency and improving sleep quality. This specific formulation is designed for gradual absorption to mimic natural nocturnal secretion.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin SR 2 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Hydroxypropyl Methyl Cellulose Sodium Alginate Microcrystalline Cellulose Carnauba wax Gelatin Capsule
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Suggested Use: One capsule per day or as directed by a healthcare professional.

Warnings & Precautions

Keep out of reach of children.

Safety sealed for your protection.

Formulation Notes

Contains no: Dairy, egg, fish, shellfish, nuts, wheat, gluten, soy, sugar, yeast, artificial preservatives or colors

Gluten free Non GMO

Sustained release

Additional Information

Store tightly closed in a cool, dry place.

cGMP Current Good Manufacturing Practice Made in the USA PNR Over 100 Partners in Research

Bio-Tech Pharmacal, Inc. Energy=Health

Metadata

Product Details

UPC / SKU6 44216 46349 7
DSLD Entry Date2020-06-24
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID229382
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.